A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Department of Radiation Oncology and Molecular Radiation Sciences uncovered a new tumor-suppressive response that could lead to novel ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Department of Radiation Oncology and Molecular Radiation Sciences ...

Rohit Kadam turns molecular research into scalable diagnostics that serve frontline clinics, not just publications.

Cold sore-causing HSV-1 doesn't just hijack cells it reconfigures the entire architecture of our DNA to aid its invasion.

Laiho holds patents on RNA polymerase 1 inhibitors, which are managed by The Johns Hopkins University in accordance with its conflict-of-interest policies.

The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...

Viruses are entirely dependent on their hosts to reproduce. They ransack living cells for parts and energy and hijack the ...

The new study, funded in part by the National Institutes of Health and published June 18 in Cell Chemical Biology, showed ...

RNA polymerase II (Pol II) briefly stalls at these sites before slowly bypassing them. However, how Pol I responds to this form of damage was previously unclear.